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Abstract OAT-Kl, a renal organic anion transporter, which 
mediates methotrexate uptake, was analyzed for mRNA 
distribution along microdissected nephron segments and the 
immunolocalization in isolated plasma membranes from rat 
kidney. By using a reverse transcription-coupled PCR, OAT-Kl 
mRNA was detected predominantly in the superficial and 
juxtamedullary proximal straight tubules. Western blotting with 
antiserum for OAT-Kl revealed that the transporter protein with 
the apparent molecular mass of 40 kDa was expressed 
exclusively in the brush-border membranes from rat kidney. 
These findings suggest that the OAT-Kl is localized in the brush-
border membranes of the renal proximal straight tubules. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Renal tubular cells play an important role in the reabsorp-
tion and excretion of anionic endogenous substances and 
xenobiotics. Methotrexate, an anionic anticancer drug, is 
widely used at high dosage in the treatment of malignancies 
and acute lymphocytic leukemia [1,2], and at relatively low 
doses in the treatment of arthritis [3]. In humans, methotrex-
ate is eliminated almost entirely as the unchanged form in 
urine, involving glomerular filtration and active tubular secre-
tion. The tubular secretory pathway for methotrexate is con-
sidered to be relatively nonspecific for a variety of organic 
anions including urate, p-aminohippurate and probenecid 
[4,5]. 
We recently isolated c D N A encoding a rat kidney-specific 
organic anion transporter, designated O A T - K l [6], which 
showed 72% amino acid identity with a rat liver organic anion 
transporting polypeptide, oatp [7]. Methotrexate and folate, 
but not j»-ammohippurate and taurocholate, were accumu-
lated by the stably transfected renal cells expressing rat 
O A T - K l [6]. The uptake of methotrexate by the rat OAT-
Kl-expressing cells was markedly inhibited by typical sub-
strates for renal organic anion transport systems, such as p-
aminohippurate, probenecid, and 4,4'-diisothiocyanostilbene-
2,2'-disulfonic acid (DIDS), although these anions were not 
transported by OAT-Kl [6]. Studies concerning the distribu-
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tion and localization of O A T - K l in the kidney should suggest 
its physiological role in renal handling of methotrexate. 
In this study, we performed reverse transcription (RT) 
coupled P C R to detect the m R N A expression of O A T - K l 
in the microdissected nephron segments, and immunoblot 
analysis for its localization in the isolated renal membranes. 
The present data suggest that the O A T - K l is primarily local-
ized in the brush-border membranes of the proximal straight 
tubules. 
2. Materials and methods 
2.1. Microdissection of rat nephron 
Rats (80-100 g) were anesthetized with sodium pentobarbital (50 
mg/kg intraperitoneally), the abdominal aorta was ligated just above 
and below the left renal artery, and the left kidney was perfused via 
the abdominal aorta with 10 ml of solution A (130 mM NaCl, 5 mM 
KC1, 1 mM NaH2P04 , 1 mM MgS04, I mM Ca lactate, 2 mM Na 
acetate, 5.5 mM D-glucose, and 10 mM JV-2-hydroxyethylpiperazine-
7V'-2-ethanesulfonic acid (HEPES), pH 7.4) [8]. The left kidney was 
then perfused with 10 ml of solution B (solution A containing 1 mg/ml 
collagenase (type 1, Sigma Chemical Co., St. Louis, MO), 1 mg/ml 
bovine serum albumin (BSA) (Sigma) and 10 mM vanadyl ribonucleo-
tide complex (VRC) (Gibco BRL, Life Technologies Inc., Gaithers-
burg, MD)) and removed. Kidney slices were cut along the cortico-
medullary axis and incubated with solution B for 30 min at 37°C 
under aeration with 100% O2. After incubation, the slices were 
washed three times with solution A. The tubules were microdissected 
to obtain the following structures: glomerulus, proximal convoluted 
tubule, proximal straight tubule, medullary thick ascending limb, cor-
tical thick ascending limb, cortical collecting duct, outer medullary 
collecting duct and inner medullary collecting duct as described pre-
viously [8] using needles under a stereomicroscope at 10°C in solution 
Al (solution A containing 10 mM VRC). Most segments were dis-
sected from superficial nephron. Only proximal straight tubule was 
dissected separately from superficial or juxtamedullary nephron. Late 
proximal straight tubule (S3) was defined as a portion within 1 mm 
length from the junction to thin descending limb and was taken from 
juxtamedullary nephron. After microdissection, 5 glomeruli and 2 mm 
of each dissected tubule segment were transferred into RT-PCR tubes, 
which contained 10 ul of ice-cold solution A2 (solution A containing 
1.7% RNase inhibitor (Boehringer Mannheim GmbH, Mannheim, 
Germany) and 5 mM dithiothreitol (DTT)) and then centrifuged at 
15 000 rpm for 5 min at 4°C. Each pellet of glomeruli or tubules was 
used for a single determination of OAT-Kl mRNA expression. 
2.2. RT-PCR 
After removal of solution A2, 3.5 ul of 0.2% Triton X-100, con-
taining > 1 U/ul of RNase inhibitor and 5 mM DTT, was added to 
solubilize the cells. The RT was performed using a cDNA synthesis 
kit (Boehringer Mannheim) [9]. The synthesized cDNA was used for 
subsequent PCR using the PCR Master (Boehringer Mannheim) with 
a set of rat OAT-Kl primers for the nucleotide sequence (sense 
strand, 5'-GTAGACACAGGGTCTGTGAATACA-3' (bases 664-
687), antisense strand, 5'-AAGGTACTGCAGCTTGTTGGTGCA-
3' (bases 1516-1539)). The predominant PCR product was predicted 
to be 876 bp in length. The tubes were placed in a Programmed 
Tempcontrol System (Astec, Tokyo, Japan) programmed as described 
[6]. 
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2.3. PCR product analysis 
After ethanol precipitation, the PCR products were separated by 
2% agarose gel electrophoresis. Following electrophoresis and ethidi-
um bromide staining, DNA bands were visualized with an ultraviolet 
transilluminator (Funakoshi, Tokyo, Japan). For Southern blot anal-
ysis, gels were blotted onto a nylon membrane Hybond-N+ (Amer-
sham International, Buckinghamshire, UK) as described [9]. Whole 
OAT-Kl cDNA was labeled with [cc-32P]dCTP (3000 Ci/mmol; 
1 Ci = 37 GBq ; Amersham), and prehybridization/hybridization was 
performed as described [6]. 
2.4. Polyclonal antibodies against rat OAT-Kl 
Polyclonal antibodies were raised against the synthetic peptide cor-
responding to the intracellular domains near the COOH-terminal 
(TDVHRNPKFKNDGEL) of rat OAT-Kl. The peptide was synthe-
sized with cysteine for its NH2-terminal (purity of 97.8% by high 
performance liquid chromatography; Peptide Institute, Osaka, Ja-
pan). After obtaining pre-immune serum, rabbit antiserum was raised 
against the peptide conjugated to keyhole limpet hemocyanin (Calbio-
chem-Behring, La Jolla, CA). A male New Zealand White rabbit (2.5 
kg) was immunized with 1 ml of conjugates (1 mg of the peptide) 
emulsified with Freund's complete adjuvant. The emulsified conju-
gates were injected for boosts every 2 weeks until the antibody was 
obtained. After each boost, blood was collected and the antibody 
production was determined by enzyme-linked immunosorbent assay. 
2.5. Affinity purification of antibody and Western blot analysis 
The antiserum used in Western blot analysis was purified by im-
munoadsorption on Immobilon membrane strips according to the 
method reported by Sambolic et al. [10] with some modifications. 
The synthetic antigen peptide was separated by 15% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to the Immobilon membrane by semi-dry electroblotting for 
30 min. A horizontal strip of membrane containing the peptide was 
verified by Western blotting, excised, washed with Tris-buffered saline 
containing Tween 20 (TBS-T, 20 mM Tris/HCl, 137 mM NaCl, 0.1% 
Tween 20, pH 7.5), and then incubated in the immune serum over-
night at 4°C to adsorb anti-OAT-Kl antibody. The strips were then 
washed with TBS-T buffer, and the immunoaffinity-adsorbed anti-
body was released by incubation in 0.1 M citrate buffer (pH 2.0) 
for 1 min under constant vortexing, followed by neutralization to 
pH 7.4 with 1 M Tris/HCl buffer (pH 10.5). The affinity-purified 
anti-OAT-Kl antibody was diluted 1:50 for Western blotting. 
Crude plasma membrane fractions were prepared from several tis-
sues of rats (200-220 g) as reported previously [11]. Brush-border and 
basolateral membranes were purified simultaneously from rat renal 
cortex and medulla as described [12]. To carry out Western blot anal-
ysis, the membrane fractions were solubilized in a solubilizing buffer 
(2% SDS, 125 mM Tris, 20% glycerol in the absence and presence of 
5% ß-mercaptoethanol), and heated at 100°C for 3 min. The samples 
were separated by 10% SDS-PAGE and transferred to polyvinylidene 
difluoride membranes (Hybond-PVDF; Amersham) by semi-dry elec-
troblotting for 30 min. The blots were blocked and washed as de-
scribed [13]. The blots were incubated with the purified antiserum 
preabsorbed with the synthetic antigen peptide (0.5 (ig/ml) or the 
primary purified antibody (1:50) overnight at 4°C. The blots were 
washed three times with TBS-T, and the bound antibody was detected 
on X-ray film by enhanced chemiluminescence with a horseradish 
peroxidase-conjugated anti-rabbit IgG antibody and cyclic diacylhy-
drazides (Amersham). 
2.6. Materials 
HEPES, Tris and Tween 20 were purchased from Nacalai Tesque 
(Kyoto, Japan). DTT was obtained from Sigma. All other chemicals 
used for the experiments were of the highest purity available. 
3. Results 
With reverse transcription and subsequent PCR, two distin-
guishable bands, which were the predicted size of 876 bp for 
OAT-Kl and the smaller size of ~800 bp for an unknown 
product, were detected from the proximal straight tubule from 
superficial nephron, and the proximal straight tubule and late 
Fig. 1. Detection of OAT-Kl mRNA in microdissected renal nephron segments by RT-PCR by agarose gels (A) and autoradiograms of corre-
sponding Southern blots (B). Each PCR amplification (30 cycles) was performed using either 5 glomeruli or a 2 mm length of renal tubule. 
A: After microdissection, 5 glomeruli and 2 mm of each dissected tubule segment were reverse-transcribed, and the cDNA synthesized was am-
plified using a set of primers for OAT-Kl as described in the text. The PCR products were separated by electrophoresis through 2% agarose 
gels and stained with ethidium bromide. B: The agarose gels were transferred onto a nylon membrane and hybridized with the [32P]dCTP-la-
beled rat OAT-Kl cDNA as a probe at high stringency. Glm, glomerulus; PCT, proximal convoluted tubule; PST, proximal straight tubule; 
MAL, medullary thick ascending limb; CAL, cortical thick ascending limb; CCD, cortical collecting duct; OMCD, outer medullary collecting 
duct; IMCD, inner medullary collecting duct. 
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Fig. 2. Western blot analysis of rat tissue membranes with antiserum for rat OAT-Kl. 50 |xg of each membrane was separated on SDS-PAGE 
(10%) under reducing conditions and blotted on PVDF membrane. A: The affinity-purified antiserum (1:50 dilution) for rat OAT-Kl was used 
as primary antibody. B: The affinity-purified antiserum (1:50 dilution) preabsorbed with the antigen peptide (0.5 |ig/ml) of rat OAT-Kl was 
used. A horseradish peroxidase-conjugated anti-rabbit IgG antibody was used for the detection of bound antibodies, and the strips of blots 
were visualized by chemiluminescence on X-ray film. The arrows indicate the position of OAT-Kl. 
proximal straight tubule (S3) from the juxtamedullary neph-
ron (Fig. 1A). The same bands were slightly detected in the 
proximal convoluted tubule and the outer medullary collect-
ing duct (Fig. 1A). When the PCR procedure was carried out 
in the absence of reverse transcriptase, neither band was de-
tected from the juxtamedullary proximal straight tubule, in-
dicating that both PCR products originated from mRNA, not 
from genomic DNA. The Southern blots of the gels demon-
strated that the OAT-Kl-specific probe hybridized to both 
PCR products, and there was no other detectable band (Fig. 
IB). 
By Western blot analysis with the affinity-purified antibody 
against rat OAT-Kl, an immunoreactive protein with the ap-
parent molecular mass of ~ 40 kDa was detected in the crude 
membrane preparations of renal cortex and medulla but not 
in those of other tissues (Fig. 2A). The immunoreactive bands 
were completely abolished when the antibody was preab-
sorbed with the antigen peptide (0.5 |ig/ml) (Fig. 2B). 
Next, we performed Western blot analysis of rat renal 
brush-border and basolateral membranes. As shown in Fig. 
3A, the ~40-kDa immunoreactive proteins were detected in 
the brush-border but not in the basolateral membranes of 
both renal cortex and medulla, under reducing conditions 
with ß-mercaptoethanol. Furthermore, under nonreducing 
conditions in which ß-mercaptoethanol was absent in the solu-
bilizing buffer for SDS-PAGE, the immunoreactive proteins 
with the same size of ~ 40 kDa appeared in the brush-border 
membranes (Fig. 3C). The ~ 4 0 kDa bands were abolished 
when the preabsorbed anti-serum for OAT-Kl was used (Fig. 
3B,D), suggesting that the positive bands observed were spe-
cific for the antigen peptide. 
4. Discussion 
In humans, an administered dose of methotrexate is recov-
ered mostly unchanged in the urine, with the renal elimination 
involving glomerular filtration, active tubular secretion and 
reabsorption. However, the renal handling mechanisms of me-
thotrexate have not yet been elucidated. Recently, we cloned a 
rat kidney-specific organic anion transporter, OAT-Kl, and 
characterized its function using the stable transfected renal 
epithelial cells, suggesting that OAT-Kl mediates basolateral 
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Fig. 3. Western blot analysis under both reducing (A, B) and nonreducing (C, D) conditions of brush-border and basolateral membranes puri-
fied from either rat kidney cortex or medulla with antiserum for rat OAT-Kl. 50 ug of each membrane was separated on SDS-PAGE (10%) 
and blotted on PVDF membrane. A and C: The affinity-purified antiserum (1:50 dilution) for rat OAT-Kl was used as primary antibody. 
B and D: The affinity-purified antiserum (1:50 dilution) preabsorbed with the antigen peptide (0.5 ug/ml) of rat OAT-Kl was used. A horse-
radish peroxidase-conjugated anti-rabbit IgG antibody was used for the detection of bound antibodies, and the strips of blots were visualized 
by chemiluminescence on X-ray film. The arrows indicate the position of OAT-Kl. BBM, brush-border membrane; BLM, basolateral mem-
brane. 
uptake of methotrexate and folate in the transfectant [6]. The 
tissue distribution and localization of OAT-Kl in the kidney 
have been remained to be identified. 
RT-PCR for mRNA from the rat microdissected nephron 
segments with specific primers for OAT-Kl resulted in two 
PCR products: one with the expected length (876 bp) for 
OAT-Kl and another with a short length (~800 bp). Both 
PCR products were found in the proximal straight tubule 
from the superficial nephron, and the proximal straight tubule 
and late proximal straight tubule (S3) from the juxtamedul-
lary nephron. The same bands were detected at a fainter level 
in the proximal convoluted tubule and the outer medullary 
collecting duct. Partial nucleotide sequencing of the shorter 
band indicated that the product was derived from oatp (un-
published data). Methotrexate is accumulated extensively in 
both the kidney cortex and medulla [6]. Therefore, we assume 
that OAT-Kl localized in the superficial and juxtamedullary 
proximal straight tubules is involved in the accumulation of 
methotrexate in the kidney. However, the possibility that oth-
er organic anion transporters localized in the proximal tubule 
participate in the renal secretion and reabsorption of metho-
trexate cannot be excluded. 
Western blot analysis showed that an immunoreactive pro-
tein with the apparent molecular mass of 40 kDa was detected 
preferentially in the renal crude plasma membranes. Previ-
ously, we found that OAT-Kl mRNA was expressed exclu-
sively in the renal cortex and medulla by both Northern blot-
ting and RT-PCR analyses [6]. Therefore, we assumed that 
the 40-kDa protein was a translation product of the OAT-Kl 
mRNA. The apparent molecular mass of 40 kDa was rela-
tively smaller than the calculated molecular mass of 74 kDa 
(without four potential sugar chains) of the OAT-Kl, suggest-
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ing proteolytic processing in the molecule. A similar event was 
reported in immunoblotting of the oatp, an organic anion 
transporting polypeptide expressed in both the liver and kid-
ney, and two alternative cleavage sites have been postulated in 
the oatp [14]. Interestingly, the proteolytic cleavage of oatp 
was observed in the kidney but not in the liver, suggesting 
differential biosynthetic processing of oatp [14]. In the case of 
oatp protein detected in the kidney, two cleaved portions of 
oatp might be linked by a disulfide bond after the internal 
processing [14]. In the present study, however, Western blot-
ting showed that the OAT-K1 transporter protein appeared as 
40 kDa under both the reducing and nonreducing conditions 
(Fig. 1A,C). Therefore, it was suggested that the OAT-K1 
transporter protein does not exist as oligomeric form linked 
by a disulfide bond. Nevertheless, we detected the immuno-
reactive protein of ~ 70 kDa in the transfected LLC-PKi cells 
(unpublished data). The difference in molecular weight of 
OAT-K1 between renal tubular cells and the transfected 
LLC-PKi cells is unknown. The physiological significance 
and precise mechanism for the proteolytic processing and 
membrane sorting of OAT-K1 should be further studied. 
The transfected LLC-PKi cells expressing OAT-K1 showed 
the enhanced uptake of methotrexate from basolateral side, 
but not from the apical side [6]. In contrast, the OAT-K1 
appeared in the brush-border membranes but not in the baso-
lateral membranes from both the renal cortex and medulla 
(Fig. 3A). Under the nonreducing condition, these immuno-
reactive bands did not shift to a higher molecular mass com-
pared to that observed under reducing conditions (Fig. 3C). 
These findings indicate that the membrane sorting mecha-
nisms in rat kidney tubular cells differ from those in the trans-
fected LLC-PKx cells. Facilitative glucose transporters (e.g. 
GLUT-1, -2, -3, -4, and -5) stably transfected in polarized 
Madin-Darby canine kidney cells have been reported to differ 
in membrane targeting [15]. GLUT-1 and -2 were found in the 
basolateral membranes, but GLUT-3 and -5 were detected in 
the apical membranes, and insulin-regulatable GLUT-4 was in 
the intracellular tubulovesicular structures. Comparison of 
functional characteristics of OAT-K1 in renal brush-border 
membranes with those in the transfected cells deserves future 
investigations. At present, whether OAT-K1 transporter con-
tributes to secretion and/or reabsorption of methotrexate in 
renal tubules is unknown. 
In conclusion, the OAT-K1 organic anion transporter is 
suggested to be localized to the brush-border membranes of 
proximal straight tubules along rat nephron. 
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